To the best of our knowledge, we here for the first time revealed that two miRNAs (miR-192 and miR-204) can suppress oncogene HOTTIP expression and HCC viability via the AGO2-mediated RNAi pathway. The gene discussed is AGO2; the disease is hepatocellular carcinoma.